2016 International Congress Archives - Page 31 of 207

12:30pm-2:00pm: Meaningful life attitudes support positive coping in patients with idiopathic Parkinson’s disease

S. Gräber, J. Meinhardt, E. Schäffer, A. Apel, D. Berg (Tübingen, Germany)

Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Measurement of effect of variable deep brain stimulation (DBS) frequencies on static postural control in Parkinson’s disease (PD) patients with bilateral STN or GPi stimulators by employing force plate

A. Deep, A. Lieberman, R. Dhall, T. Lockhart, S. Shafer, C. Frames, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi, S. Syed (Phoenix, AZ, USA)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Measurement of night time sleep using an accelerometry based system

M. Horne, S. McGregor, G. Hamilton, D. O'Driscoll, R. Blaze, P. Churchward (Parkville, Australia)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Measuring interdependence of the health status of people with Parkinson’s disease and their spouses

F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)

Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients

S.E. Oyler, J.E. Fleisher, M.M. Sweeney, A.C. Lemen, A. Fazl, G. Dacpano, R.M. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)

Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: MicroRNA as diagnostic biomarkers in Parkinson’s disease and multiple system atrophy

C.C. Starhof, K. Winge, N. Heegaard, A.M. Hejl (København, Denmark)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Midbrain atrophy differentially progresses between Richardson’s Syndrome, progressive supranuclear palsy-parkinsonism and Parkinson’s disease: Longitudinal MRI study

Y.E. Huh, M. Hwang, J.K. Park, J.W. Cho (Seoul, Korea)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Mild Parkinsonian signs and TIA/stroke

J.L. Adams, N. Dahodwala (Rochester, NY, USA)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Minimal impact of “interleaving” on neuromodulation device battery drain when interleave frequency is halved

Y.M. Fernandez, D.L. Caputo, D.P. Schneider, S.F. Danish, R.J. Dipaola, E.L. Hargreaves (New Brunswick, NJ, USA)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Modeling trajectories of brain damage in progressive supranuclear palsy: A longitudinal multimodal MRI study

F. Caso, F. Agosta, M. Lukic-Jecmenica, I. Petrovic, P. Valsasina, P.M. Ferraro, A. Meani, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2